Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Appoints Two Additional Prominent Industry Executives to Strategic Advisory Board
Atossa Announces $13.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
Atossa Genetics Receives Positive Interim Safety Review from Independent Safety Committee in Phase 1 Topical Endoxifen Dose Escalation Study in Men
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!